anti-galectin-3 mAb (Memorial Sloan Kettering Cancer Center/Weil Cornell Medical College)

N/A

Report date: 2025/03/14 16:22:16

Base Information

Drug Nameanti-galectin-3 mAb (Memorial Sloan Kettering Cancer Center/Weil Cornell Medical College)
Drug Alias Name14D11.2D2
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionGalectin-3 inhibitors
TargetsGalectin-3
Therapy Area/IndicationsOvarian Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesMemorial Sloan Kettering Cancer Center
China Registration ClassN/A

Develop Information

Active CompaniesWeill Medical College of Cornell UniversityMemorial Sloan Kettering Cancer Center
Inactive CompaniesN/A
Active IndicationsOvarian Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A